Y
LIVE

Serial Number

75121629

Owner

Indoor Biotechnologies Limited

Attorney

Michael J. Hertz

Filing Date

Jun 14, 1996

Add to watchlist:

No watchlists yet
View on USPTO

Y Trademark

Serial Number: 75121629 • Registration: 2183307

Y is a trademark filed by Indoor Biotechnologies Limited on June 14, 1996. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Indoor Biotechnologies Limited (2 trademarks)

123 Deansgate
MANCHESTER, M23 2BU , GB

Entity Type: 03

Trademark Details

Filing Date

June 14, 1996

Registration Date

August 25, 1998

Published for Opposition

June 2, 1998

Goods & Services

diagnostic assay preparations and substances for clinical or medial use; labelled and unlabelled polyclonal and monoclonal antibodies for clinical or medical laboratory use or for environmental analysis for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; allergen analysis and purification preparations and substances, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; pharmaceutical preparations, namely, epitope mapping systems, composed of antibodies, for use in the treatment of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; pharmaceutical preparations, namely, rapid test devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; pharmaceutical preparations, namely, allergen detection devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air foods, or any other substances; assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; diagnostic assay systems, composed of antibodies for detection of antibodies in blood and other body fluids; allergen analysis and purification systems, composed of antibodies, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; epitope mapping systems, composed of antibodies and natural or recombinant allergens, for use in diagnosis and treatment of allergic diseases

diagnostic assay preparations for scientific or research use; labelled and unlabelled polyclonal and monoclonal antibodies for scientific or research use or for use in the manufacture of allergen detection systems and devices or allergen purification systems; allergen analysis and purification preparations and substances composed of antibodies or allergens for scientific or research use or for use in the manufacture of allergen detection systems and devices or allergen purification systems; assay systems, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; diagnostic assay systems, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; rapid test devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; and allergen detection devices, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances

medical apparatus, namely, assay systems, composed of plastic microtiter plates, nitrocellulose membranes and gel based affinity matrices, for detection of antibodies in blood and other body fluids; medical apparatus, namely, diagnostic assay systems, composed of plastic microtiter plates, nitrocellulose membranes and gel based affinity matrices, for detection of antibodies in blood and other body fluids; medical apparatus, namely, allergen analysis and purification systems, composed of plastic microtiter plates, antibody immunoadsorbents prepared using agarose beads, agarose and acrylamide gels, plastic laboratory columns and tubing, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; medical apparatus, namely, allergen sampling and detection systems, composed of plastic dust collection devices with inner nylon membrane filters, plastic microtiter plates, plastic cassettes containing antibody coated nitrocellulose membranes, and nitrocellulose dipsticks for use in diagnosis and treatment of allergic diseases

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 18, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 18, 2022 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 20, 2017 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Nov 20, 2017 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 20, 2017 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 20, 2017 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 24, 2017 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Aug 25, 2017 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 11, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2013 REAP
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 10, 2008 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 10, 2008 89AG
ASSIGNED TO PARALEGAL
May 6, 2008 PLGL
TEAS SECTION 8 & 9 RECEIVED
Apr 24, 2008 E89R
CASE FILE IN TICRS
Aug 14, 2007 CFIT
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 18, 2003 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Oct 8, 2003 815F
PAPER RECEIVED
Feb 20, 2003 MAIL
REGISTERED-PRINCIPAL REGISTER
Aug 25, 1998 R.PR
PUBLISHED FOR OPPOSITION
Jun 2, 1998 PUBO
NOTICE OF PUBLICATION
May 1, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 1998 CNSA
EXAMINER'S AMENDMENT MAILED
Mar 5, 1998 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 1998 CRFA
NON-FINAL ACTION MAILED
Jul 28, 1997 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 1997 CRFA
NON-FINAL ACTION MAILED
Nov 22, 1996 CNRT
ASSIGNED TO EXAMINER
Nov 21, 1996 DOCK
ASSIGNED TO EXAMINER
Nov 15, 1996 DOCK